0001562180-19-004967.txt : 20190927 0001562180-19-004967.hdr.sgml : 20190927 20190927160530 ACCESSION NUMBER: 0001562180-19-004967 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190925 FILED AS OF DATE: 20190927 DATE AS OF CHANGE: 20190927 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Laliberte Kevin CENTRAL INDEX KEY: 0001709417 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38135 FILM NUMBER: 191122158 MAIL ADDRESS: STREET 1: C/O DOVA PHARMACEUTICALS, INC. STREET 2: 240 LEIGH FARM ROAD, SUITE 245 CITY: DURHAM STATE: NC ZIP: 27707 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Dova Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001685071 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 813858961 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 240 LEIGH FARM ROAD CITY: DURHAM STATE: NC ZIP: 27707 BUSINESS PHONE: 919-806-4487 MAIL ADDRESS: STREET 1: 240 LEIGH FARM ROAD CITY: DURHAM STATE: NC ZIP: 27707 FORMER COMPANY: FORMER CONFORMED NAME: Dova Pharmaceuticals, Inc. DATE OF NAME CHANGE: 20160919 4 1 primarydocument.xml PRIMARY DOCUMENT X0306 4 2019-09-25 false 0001685071 Dova Pharmaceuticals Inc. DOVA 0001709417 Laliberte Kevin C/O DOVA PHARMACEUTICALS, INC. 240 LEIGH FARM ROAD, SUITE 245 DURHAM NC 27707 false true false false Sr. VP, Product Development Common Stock 2019-09-25 4 S false 3100.00 20.00 D 8457.00 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan based on a limit price order adopted by the Reporting Person. /s/ Marc Banjak, Attorney-in-Fact 2019-09-27